JPY983.00
6.62% yesterday
Tokyo, Jun 27, 08:15 am CET
ISIN
JP3495000006
Symbol
4506
Index
Sector
Industry

Sumitomo Dainippon Pharma Stock price

JPY983.00
+210.00 27.17% 1M
+412.00 72.15% 6M
+420.00 74.60% YTD
+608.00 162.13% 1Y
-94.00 8.73% 3Y
-470.00 32.35% 5Y
-331.96 25.24% 10Y
-35.22 3.46% 20Y
Tokyo, Closing price Fri, Jun 27 2025
+61.00 6.62%
ISIN
JP3495000006
Symbol
4506
Index
Sector
Industry

Key metrics

Basic
Market capitalization
JPY366.3b
Enterprise Value
JPY631.8b
Net debt
JPY265.5b
Cash
JPY40.0b
Shares outstanding
397.3m
Valuation (TTM | estimate)
P/E
16.52 | 14.14
P/S
0.92 | 0.97
EV/Sales
1.58 | 1.67
EV/FCF
negative
P/B
2.30
Dividends
DPS
JPY0.00
Yield 1Y | 5Y
0.00% | 1.44%
Growth 1Y | 5Y
- | -100.00%
Payout 1Y | 3Y
0.00% | -2.28%
Increased
0 Years
Financials (TTM | estimate)
Revenue
JPY398.8b | JPY377.5b
EBITDA
JPY55.3b | JPY77.8b
EBIT
JPY29.7b
Net Income
JPY23.6b | JPY27.6b
Free Cash Flow
JPY-9.7b
Growth (TTM | estimate)
Revenue
26.79% | -5.36%
EBITDA
117.11% | 40.70%
EBIT
108.24%
Net Income
107.50% | 16.84%
Free Cash Flow
96.22%
Margin (TTM | estimate)
Gross
61.53%
EBITDA
13.86% | 20.60%
EBIT
7.45%
Net
5.93% | 7.32%
Free Cash Flow
-2.43%
Financial Health
Equity Ratio
22.82%
Return on Equity
13.95%
ROCE
5.92%
ROIC
7.84%
Debt/Equity
1.80
More
EPS
JPY59.49
FCF per Share
JPY-24.42
Short interest
-
Employees
4.98k
Rev per Employee
JPY80.09m
Show more

Is Sumitomo Dainippon Pharma a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Sumitomo Dainippon Pharma Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Sumitomo Dainippon Pharma forecast:

1x Buy
7%
6x Hold
43%
7x Sell
50%

Analyst Opinions

14 Analysts have issued a Sumitomo Dainippon Pharma forecast:

Buy
7%
Hold
43%
Sell
50%

Financial data from Sumitomo Dainippon Pharma

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
398,832 398,832
27% 27%
100%
- Direct Costs 153,437 153,437
21% 21%
38%
245,395 245,395
31% 31%
62%
- Selling and Administrative Expenses 180,177 180,177
58% 58%
45%
- Research and Development Expense 49,865 49,865
56% 56%
13%
55,271 55,271
117% 117%
14%
- Depreciation and Amortization 25,562 25,562
32% 32%
6%
EBIT (Operating Income) EBIT 29,709 29,709
108% 108%
7%
Net Profit 23,634 23,634
108% 108%
6%

In millions JPY.

Don't miss a Thing! We will send you all news about Sumitomo Dainippon Pharma directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sumitomo Dainippon Pharma Co., Ltd. engages in manufacture, sale, import, and export of pharmaceutical products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment manufactures and sells generic and prescription drugs in Japan, North America, China, and other overseas countries. The Other Business segment division includes food ingredients, additives, chemical products, veterinary drugs, and diagnostic reagents. The company was founded on May 14, 1897 and is headquartered in Osaka, Japan.

Head office Japan
CEO Toru Kimura
Employees 4,980
Founded 1897
Website www.sumitomo-pharma.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today